ACADIA Pharmaceuticals Inc (ACAD)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 1,187,760 | 748,956 | 587,812 | 700,122 | 782,616 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,187,760K
= 0.00
The debt-to-assets ratio for ACADIA Pharmaceuticals Inc has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its assets during this period. A debt-to-assets ratio of 0.00 signifies a low risk level related to financial leverage, as there is no debt contributing to the company's asset base. It suggests that the company may have been reliant on equity financing or other sources of funding instead of debt to support its operations and investment activities.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
ACADIA Pharmaceuticals Inc
ACAD
0.00
Abbott Laboratories
ABT
0.00
AbbVie Inc
ABBV
0.00
Alkermes Plc
ALKS
0.00
Amphastar P
AMPH
0.39
ANI Pharmaceuticals Inc
ANIP
0.00
Arcus Biosciences Inc
RCUS
0.00
Biomarin Pharmaceutical Inc
BMRN
0.09
Bristol-Myers Squibb Company
BMY
0.51
Catalyst Pharmaceuticals Inc
CPRX
0.00
Collegium Pharmaceutical Inc
COLL
0.42